Archiv der Kategorie ‘Gilead Sciences‘

Gilead Sciences (GILD) Upgrade from Hold to Buy – Analyst rating from Argus

Thursday, den 13. June 2013

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4

Sunday, den 3. March 2013

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4

Saturday, den 2. March 2013

Gilead Sciences Completes Acquisition of YM BioSciences

Sunday, den 10. February 2013

Has Gilead Sciences Become the Perfect Stock?

Sunday, den 10. February 2013

Gilead Sciences kaufen – New Analyst Rating from boerse.de-Aktienbrief

Monday, den 14. January 2013

Gilead Sciences kaufen – New Analyst Rating from Aktienservice Research

Friday, den 11. January 2013

Gilead Sciences kaufen – New Analyst Rating from boerse.de-Aktienbrief

Friday, den 11. January 2013

Gilead Sciences overweight – New Analyst Rating from Piper Jaffray & Co.

Monday, den 3. December 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Friday, den 16. November 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Thursday, den 15. November 2012

Gilead Sciences buy – New Analyst Rating from Stifel, Nicolaus & Co., Inc.

Wednesday, den 14. November 2012

Gilead Sciences buy – New Analyst Rating from Deutsche Bank Securities

Wednesday, den 14. November 2012

Gilead Sciences buy – New Analyst Rating from Stifel, Nicolaus & Co., Inc.

Tuesday, den 13. November 2012

Gilead Sciences neutral – New Analyst Rating from Credit Suisse Group

Tuesday, den 13. November 2012

Gilead Sciences buy – New Analyst Rating from UBS AG

Wednesday, den 3. October 2012

Gilead Sciences buy – New Analyst Rating from UBS AG

Friday, den 31. August 2012

Gilead Sciences buy – New Analyst Rating from UBS AG

Thursday, den 30. August 2012

Gilead Sciences overweight – New Analyst Rating from JP Morgan Chase & Co.

Monday, den 20. August 2012

Gilead Sciences buy – New Analyst Rating from Citigroup Corp.

Friday, den 17. August 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Monday, den 16. July 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Thursday, den 12. July 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Friday, den 29. June 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Monday, den 25. June 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Friday, den 22. June 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Wednesday, den 20. June 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Tuesday, den 19. June 2012

Gilead Sciences kaufen – New Analyst Rating from Der Aktionaer

Friday, den 25. May 2012

Gilead Sciences outperform – New Analyst Rating from Needham & Company, LLC

Monday, den 30. April 2012

Gilead Sciences buy – New Analyst Rating from Citigroup Corp.

Monday, den 30. April 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Wednesday, den 21. March 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Tuesday, den 20. March 2012

Gilead Sciences buy – New Analyst Rating from Stifel, Nicolaus & Co., Inc.

Friday, den 16. March 2012

Gilead Sciences overweight – New Analyst Rating from JP Morgan Chase & Co.

Friday, den 24. February 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Thursday, den 23. February 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Friday, den 17. February 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Thursday, den 16. February 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Monday, den 6. February 2012

Gilead Sciences outperform – New Analyst Rating from Robert W. Baird & Co. Incorporated

Monday, den 6. February 2012

Gilead Sciences buy – New Analyst Rating from Needham & Company, LLC

Monday, den 6. February 2012

Gilead Sciences buy – New Analyst Rating from Deutsche Bank Securities

Monday, den 6. February 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Wednesday, den 25. January 2012

Gilead Sciences outperform – New Analyst Rating from RBC Capital Markets

Friday, den 20. January 2012

Gilead Sciences buy – New Analyst Rating from Needham & Company, LLC

Monday, den 9. January 2012

Gilead Sciences neutral – New Analyst Rating from Credit Suisse Group

Monday, den 12. December 2011